Highlighted Papers Modulation of Peripheral m-Opioid Analgesia by s 1 Receptors

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects.

  2013cited by this paper
• A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease

  2013cited by this paper
• Sigma 1 receptor: a new therapeutic target for pain.

  2013cited by this paper
• Potentiation of morphine-induced mechanical antinociception by σ₁ receptor inhibition: role of peripheral σ₁ receptors.

  2013cited by this paper
• Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice.

  2012cited by this paper
• Dissecting the relative contribution of central versus peripheral opioid analgesia: Are the analgesic and adverse effects of opioids inseparable?

  2012influential reference
• Pharmacological properties of S1RA, a new sigma‐1 receptor antagonist that inhibits neuropathic pain and activity‐induced spinal sensitization

  2012cited by this paper
• Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids

  2012influential reference
• Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand.

  2012cited by this paper
• Functional Selectivity at the μ-Opioid Receptor: Implications for Understanding Opioid Analgesia and Tolerance

  2011cited by this paper
• Mu opioid receptors in pain management.

  2011cited by this paper
• Novel potent and selective σ ligands: evaluation of their agonist and antagonist properties.

  2011cited by this paper
• Molecular mechanisms of opioid receptor-dependent signaling and behavior.

  2011cited by this paper
• Peripherally acting opioids and clinical implications for pain control.

  2011cited by this paper
• Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes

  2010cited by this paper
• σ1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor Binding

  2010influential reference
• Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers’ diarrhoea

  2010cited by this paper
• A Pharmacokinetic and Pharmacodynamic Study of Oral Oxycodone in a Human Experimental Pain Model of Hyperalgesia

  2010cited by this paper
• Sigma‐1 receptors regulate activity‐induced spinal sensitization and neuropathic pain after peripheral nerve injury

  2009cited by this paper
• Sigma‐1 receptors are essential for capsaicin‐induced mechanical hypersensitivity: Studies with selective sigma‐1 ligands and sigma‐1 knockout mice

  2009cited by this paper
• Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors

  2009cited by this paper
• Selective sigma-1 (sigma1) receptor antagonists: emerging target for the treatment of neuropathic pain.

  2009cited by this paper
• Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)

  2008cited by this paper
• Faculty Opinions recommendation of Methylnaltrexone for opioid-induced constipation in advanced illness.

  2008cited by this paper
• Methylnaltrexone in the treatment of opioid-induced constipation

  2008influential reference
• Opioid complications and side effects.

  2008cited by this paper
• Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands

  2008cited by this paper
• Differences between and combinations of opioids re-visited

  2008cited by this paper
• Morphine and ABT-594 (a nicotinic acetylcholine agonist) exert centrally mediated antinociception in the rat cyclophosphamide cystitis model of visceral pain.

  2008cited by this paper
• Irreversible blockade of sigma‐1 receptors by haloperidol and its metabolites in guinea pig brain and SH‐SY5Y human neuroblastoma cells

  2007cited by this paper
• Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study.

  2007cited by this paper
• In vivo evaluation of (+)-MR200 as a new selective sigma ligand modulating MOP, DOP and KOP supraspinal analgesia.

  2006influential reference
• Differences in the allosteric modulation by phenytoin of the binding properties of the σ1 ligands [3H](+)‐pentazocine and [3H]NE‐100

  2006cited by this paper
• Analgesic effects of loperamide in bone cancer pain in mice.

  2005cited by this paper
• Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effect of Buprenorphine and Fentanyl in Rats: Role of Receptor Equilibration Kinetics

  2005cited by this paper
• Analgesic effects of morphine and loperamide in the rat formalin test: interactions with NMDA receptor antagonists.

  2005cited by this paper
• Phenytoin differentially modulates the affinity of agonist and antagonist ligands for σ1 receptors of guinea pig brain

  2005cited by this paper
• Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice

  2005cited by this paper
• Multiple opiate receptors: déjà vu all over again.

  2004cited by this paper
• Mu-Opiate Receptor and Beta-Endorphin Expression in Nerve Endings and Keratinocytes in Human Skin

  2004cited by this paper
• Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.

  2004cited by this paper
• Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.

  2002cited by this paper
• Sigma1 receptor modulation of opioid analgesia in the mouse.

  2002cited by this paper
• Cloning and characterization of a mouse sigma1 receptor.

  1998influential reference
• Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor.

  1997influential reference
• Differential activities of intrathecal MK‐801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve‐injured rats

  1997cited by this paper
• Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism.

  1995cited by this paper
• Subgroups among μ‐opioid receptor agonists distinguished by ATP‐sensitive K+ channel‐acting drugs

  1995cited by this paper
• Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.

  1995cited by this paper
• Descending control of pain.

  1995cited by this paper
• Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy.

  1995cited by this paper
• Selective antagonism of opioid analgesia by a sigma system.

  1994cited by this paper
• Functional antagonism of morphine analgesia by (+)-pentazocine: evidence for an anti-opioid sigma 1 system.

  1993cited by this paper
• Sigma receptors: biology and function.

  1990cited by this paper
• Antinociceptive effects of intrathecal opioids, noradrenaline and serotonin in rats: mechanical and thermal algesic tests.

  1985cited by this paper
• Ethical guidelines for investigations of experimental pain in conscious animals.

  1983cited by this paper

• No citing papers are available for this paper.